Clayton Dubilier & Rice’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,732,300
Closed -$704M 8
2022
Q3
$704M Hold
33,732,300
7.23% 4
2022
Q2
$700M Buy
33,732,300
+15,436
+0% +$275K 6.19% 5
2022
Q1
$566M Hold
33,716,864
4.59% 5
2021
Q4
$673M Hold
33,716,864
4.82% 5
2021
Q3
$612M Hold
33,716,864
4.82% 5
2021
Q2
$910M Buy
33,716,864
+40,035
+0.1% +$1.12M 7.57% 3
2021
Q1
$1.01B Hold
33,676,829
36.95% 1
2020
Q4
$968M Buy
33,676,829
+8,246,585
+32% +$223M 43.08% 1
2020
Q3
$620M Buy
25,430,244
+14,357,478
+130% +$310M 33.28% 1
2020
Q2
$198M Buy
11,072,766
+6,288
+0.1% +$82.6K 17.13% 4
2020
Q1
$90.1M Sell
11,066,478
-198,720
-2% -$2.27M 12.32% 4
2019
Q4
$149M Hold
11,265,198
10.94% 4
2019
Q3
$134M Hold
11,265,198
9.92% 4
2019
Q2
$276M Hold
11,265,198
21.35% 3
2019
Q1
$362M Buy
+11,265,198
New +$400M 30.03% 2

Other funds holding CVET

Clayton Dubilier & Rice's CVET Position: Q4 2022 in Review

Clayton Dubilier & Rice sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 33,732,300 shares — an estimated $704M sold.

Clayton Dubilier & Rice first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $1.01B in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Clayton Dubilier & Rice reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clayton Dubilier & Rice sold 33,732,300 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $704M.
  • Clayton Dubilier & Rice first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Clayton Dubilier & Rice's Covetrus, Inc. Common Stock position peaked at $1.01B in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Clayton Dubilier & Rice's 13F filing for Q4 2022, filed 30 Jan 2023.